Tacrolimus extended-release - Veloxis Pharmaceuticals
At a glance
- Drug Originator LifeCycle Pharma
- Drug Licenced by Chiesi Farmaceutici; Endo, Inc.; taiba
- Drug Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antiglaucomas; Antipsoriatics; Antirheumatics; Eye disorder therapies; Lactones; Macrolides; Skin disorder therapies; Urologics; Vascular disorder therapies
- Mechanism of Action Bone morphogenetic protein receptor type II modulators; Calcineurin inhibitors; Cytokine inhibitors; Immunosuppressants; T cell activation inhibitors
- USA Patent Applicants VELOXIS PHARMS INC
- USA Patents 24
- NDAs 1
- International Patents 30
Disclaimer